drugset
drugset / Trial / NCT05970354

EMLA Cream as Analgesic for Outpatient Gynecological Procedures

NCT05970354 ↗

Phase 4 Enrolling by invitation 400 enrolled CAMC Health System
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The goal of this clinical trial is to compare pain perception in the study participant population undergoing the following gynecological procedures: Intra Uterine Device (IUD) insertion, hysteroscopy, and endometrial biopsy and given either Eutectic Mixture of Local Anesthetics (EMLA) cream or a placebo. The main question to answer is: • Does EMLA cream reduce pain when administered during the following gynecological procedures: IUD insertion, hysteroscopy, and endometrial biopsy? Participants will be asked to do assess their pain on the Visual Analogue Scale through 3 times during the procedure. Researchers will compare the study group with those receiving placebo group to see if there is a difference in pain scores.

Timeline

Start
2023-09-15
Primary completion
2024-12-31
Completion
2025-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2.5 % Topical
Subject prilocaine Small molecule 2.5 % Topical

Indications

No indication recorded.